Copyright
©The Author(s) 2015.
World J Biol Chem. Aug 26, 2015; 6(3): 121-138
Published online Aug 26, 2015. doi: 10.4331/wjbc.v6.i3.121
Published online Aug 26, 2015. doi: 10.4331/wjbc.v6.i3.121
Knockout mice with cleft palates | Humans | ||||
Gene/category | Protein | Ref. | OMIM | Syndrome | CL/P |
Growth factors, antagonist, and receptors | |||||
Acvr1/Alk2 | Activin A receptor, type I | [33] | 1102576 | Fibrodysplasia ossificans progressiva | nr |
(Wnt1-Cre-mediated ablation) | |||||
Acvr2a | Activin A receptor, type IIA | [34] | 1102581 | nr | nr |
Bmp4 | Bone morphogenetic protein 4 | [35] | 1112262 | Microphthalmia, syndromic 6 | r |
Orofacial cleft 11 | |||||
Bmp7 | Bone morphogenetic protein 7 | [36] | 1112267 | nr | nr |
Bmpr1a/Alk3 | Bone morphogenetic protein receptor, type IA | [35] | 1601299 | Juvenile polyposis syndrome, | nr |
(Nestin-Cre-mediated ablation) | Polyposis syndrome | ||||
Chrd | Chordin | [37] | 1603475 | nr | nr |
Ctgf | Connective tissue growth factor | [38] | 1121009 | nr | nr |
Edn1 | Endothelin 1 | [39] | 2131240 | Auriculocondylar syndrome 3 | r |
Egfr | Epidermal growth factor receptor | [17] | 1131550 | nr | nr |
Fgf9 | Fibroblast growth factor 9 | [40] | 1600921 | uc | nr |
Fgf10 | Fibroblast growth factor 10 | [13,41] | 1602115 | Aplasia of lacrimal and salivary glands | nr |
LADD syndrome | |||||
Fgf18 | Fibroblast growth factor 18 | [42,43] | 1603726 | nr | nr |
Fgfr1 | Fibroblast growth factor receptor 1 | [44] | 1136350 | Nonsyndromic cleft lip/palate | r |
Hartsfield syndrome | |||||
Hypogonadotropic hypogonadism 2 | |||||
Pfeiffer syndrome | |||||
Fgfr2 | Fibroblast growth factor receptor 2 | [13,45] | 1176943 | Apert syndrome | r |
(knockout) (Krt14-Cre-mediated ablation) | Crouzon syndrome | ||||
Pfeiffer syndrome | |||||
Saethre-Chotzen syndrome | |||||
Fst | Follistatin | [46] | 1136470 | nr | nr |
Gabrb3 | Gamma-aminobutyric acid A receptor, beta 3 | [47] | 1137192 | Epilepsy, childhood absence, susceptibility to, 5 | r |
Gdf11/Bmp11 | Growth differentiation factor 11 | [48] | 1603936 | nr | nr |
Gpr124 | G protein-coupled receptor 124 | [49] | 1606823 | nr | nr |
Inhba | Inhibin, beta A/activin A | [50] | 1147290 | nr | nr |
Pdgfc | Platelet-derived growth factor C | [51] | 1608452 | nr | r [52] |
Pdgfra | Platelet-derived growth factor receptor, alpha polypeptide | [53,54] | 1173490 | Gastrointestinal stromal tumor, somatic | r |
(knockout) (Wnt1-Cre-mediated ablation) | Hypereosinophilic syndrome, idiopathic, resistant to imatinib | ||||
Tgfb2 | Transforming growth factor, beta 2 | [55] | 1190220 | Loeys-Dietz syndrome, type 4 | r |
Tgfb3 | Transforming growth factor, beta 3 | [15,16,18] | 1190230 | Arrhythmogenic right ventricular dysplasia 1 | r |
Tgfbr1/Alk5 | Transforming growth factor, beta receptor I | [56,57] | 1190181 | Loeys-Dietz syndrome, type 1 | r |
(Wnt1-Cre-, and Nestin-Cre-mediated ablation) | |||||
Tgfbr2 | Transforming growth factor, beta receptor II | [12,58] | 1190182 | Loeys-Dietz syndrome, type 2 | r |
(Wnt1-Cre-, and KRT14-Cre-mediated ablation) | |||||
Vegfa | Vascular endothelial growth factor A | [59] | 2192240 | nr | nr |
Membrane proteins | |||||
Ceacam1 | Carcinoembryonic antigen-related cell adhesion molecule 1 | [60] | 1109770 | nr | nr |
Efna5 | Ephrin A5 | [61] | 1601535 | nr | nr |
Efnb1 | Ephrin B1 | [62] | 1300035 | Craniofrontonasal dysplasia | r |
Efnb2 | Ephrin B2 | [63] | 1600527 | nr | nr |
Fzd2 | Frizzled class receptor 2 | [64] | 1600667 | nr | nr |
Itga5 | Integrin alpha 5 | [65,66] | 1135620 | nr | nr |
(knockout) (Mesp1-Cre-mediated ablation) | |||||
Itgb1 | Integrin beta 1 | [67] | 1135630 | nr | nr |
(Col2a1-Cre-mediated ablation) | |||||
Itgb8 | Integrin beta 8 | [68] | 1604160 | nr | nr |
Jag1 | Jagged1 | [69] | 2601920 | Alagille syndrome | nr |
(Wnt1-Cre-mediated ablation) | |||||
Jag2 | Jagged2 | [70] | 1602570 | nr | nr |
Kcnj2 | Potassium inwardly-rectifying channel, subfamily J, member 2 | [71] | 1600681 | Andersen syndrome | r |
Atrial fibrillation, familial, 9 | |||||
Short QT syndrome 3 | |||||
Lrp6 | Low density lipoprotein receptor-related protein 6 | [72] | 1603507 | nr | nr |
Ror2 | Receptor tyrosine kinase-like orphan receptor 2 | [73] | 1602337 | Robinow syndrome, autosomal recessive | r |
Brachydactyly, type B1 | |||||
Ryk | Receptor-like tyrosine kinase | [74] | 1600524 | nr | nr |
Ryr1 | Ryanodine receptor 1, skeletal muscle | [75] | 1180901 | Central core disease | nr |
King-Denborough syndrome | |||||
Minicore myopathy with external ophthalmoplegia | |||||
Sc5d/Sc5dl | Sterol-C5-desaturase (fungal ERG3, delta-5-desaturase) homolog (S. cerevisae) | [76] | 1602286 | Lathosterolosis | nr |
Shh | Sonic hedgehog | [13,77] | 1600725 | Holoprosencephaly-3 | r |
(KRT14-Cre-, and Sox2-Cre-mediated ablation) | Microphthalmia with coloboma 5 | ||||
Single median maxillary central incisor | |||||
Smo/Smoh | Smoothened, frizzled class receptor | [78] | 1601500 | Basal cell carcinoma, somatic | nr |
(Wnt1-Cre-mediated ablation) | |||||
Tctn2 | Tectonic family member 2 | [79] | 1613846 | Meckel syndrome 8 | r |
Wls/Gpr177 | Wntless homolog (Drosophila) | [80] | 1611514 | nr | nr |
(Wnt1-Cre-mediated ablation) | |||||
Wnt5a | Wingless-type MMTV integration site family, member 5A | [81] | 1164975 | Robinow syndrome, autosomal dominant | r |
Wnt9b | Wingless-type MMTV integration site family, member 9B | [82,83] | 1602864 | nr | nr |
(knockout) (Foxg1-Cre-mediated ablation) | |||||
Transcription and nucleolar factors | |||||
Alx1 | Aristaless-like homeobox 1 | [84] | 1601527 | Frontonasal dysplasia 3 | r |
Alx3 | Aristaless-like homeobox 3 | [85] | 1606014 | Frontonasal dysplasia 1 | r |
Alx4 | Aristaless-like homeobox 4 | [85] | 1605420 | Frontonasal dysplasia 2 | Cleft alae nasi |
Parietal foramina 2 | |||||
Craniosynostosis 5 | |||||
Anp32b | Acidic (leucine-rich) nuclear phosphoprotein 32 family, member B | [86] | nr | nr | nr |
Arid5 | AT-rich interaction domain-containing protein 5A | [87] | 1611583 | nr | nr |
Asxl1 | Additional sex combs like 1 | [88] | 1612990 | Bohring-Opitz syndrome | r |
Myelodysplastic syndrome, somatic | |||||
Barx1 | BarH-like homeobox 1 | [89] | 1603260 | nr | nr |
Cdc42 | Cell division cycle 42 | [90] | 1116952 | nr | nr |
(Prrx1-Cre-mediated ablation) | |||||
Chd7 | Chromodomain helicase DNA binding protein 7 | [91,92] | 1608892 | CHARGE syndrome | r |
(heterozygotes) (Wnt1-Cre-mediated ablation) | Hypogonadotropic hypogonadism 5 with or without anosmia | ||||
Cited2 | CBP/p300-interacting transactivator, with Glu/Asp-rich C-terminal domain, 2 | [93] | 1602937 | Atrial septal defect 8 | nr |
Ventricular septal defect 2 | |||||
Crebbp/Cbp | CREB binding protein | [94] | 1600140 | Rubinstein-Taybi syndrome | nr |
Dlx1 | Distal-less homeobox 1 | [95] | 1600029 | nr | nr |
Dlx2 | Distal-less homeobox 2 | [95] | 1126255 | nr | nr |
Dlx5 | Distal-less homeobox 5 | [96,97] | 1600028 | Split-hand/foot malformation 1 with sensorineural hearing loss | r |
Dph1/Ovca1 | DPH1 homolog (S. cerevisiae) | [98] | 1603527 | nr | nr |
Eya1 | Eyes absent 1 homolog (Drosophila) | [99] | 1601653 | Branchiootic syndrome 1 | r |
Branchiootorenal syndrome 1, with or without cataracts | |||||
Anterior segment anomalies with or without cataract | |||||
Foxc2/Mfh1 | Forkhead box C2 | [100] | 1602402 | Lymphedema-distichiasis syndrome | r |
Foxd3 | Forkhead box D3 | [101] | 1611539 | uc | nr |
(Wnt1-Cre-mediated ablation) | |||||
Foxe1/Titf2/Fkhl15 | Forkhead box E1 | [102] | 1602617 | Bamforth-Lazarus syndrome | r |
Nonsyndromic orofacial clefting | |||||
Foxf2 | Forkhead box F2 | [103] | 1603250 | nr | nr |
Gbx2 | Gastrulation brain homeobox 2 | [104] | 1601135 | nr | nr |
Gli2 | GLI family zinc finger 2 | [8] | 1165230 | Culler-Jones syndrome | r |
Holoprosencephaly-9 | |||||
Gli3 | GLI family zinc finger 3 | [105] | 1165240 | Greig cephalopolysyndactyly syndrome | r |
Pallister-Hall syndrome | |||||
Gsc | Goosecoid homeobox | [106] | 1138890 | Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities | nr |
Hand2/dHand | Heart and neural crest derivatives expressed 2 | [107] | 1602407 | nr | nr |
Hic1 | Hypermethylated in cancer 1 | [108] | 1603825 | nr | nr |
Hoxa2 | Homeobox A2 | [19] | 1604685 | Microtia with or without hearing impairment (AD) | r |
Microtia, hearing impairment, and cleft palate (AR) | |||||
Irf6 | Interferon regulatory factor 6 | [109,110] | 1607199 | van der Woude syndrome | r |
Orofacial cleft 6 | |||||
Popliteal pterygium syndrome 1 | |||||
Jmjd6/Ptdsr | Jumonji domain containing 6 | [111] | 1604914 | nr | nr |
Kat6a/Moz/Myst3 | K (lysine) Acetyltransferase 6A | [112] | 1601408 | nr | nr |
Lhx7 | LIM homeobox gene 7 | [113] | nr | nr | nr |
Lhx8 | LIM homeobox gene 8 | [11] | 1604425 | nr | r |
Luzp1 | Leucine zipper protein 1 | [114] | 1601422 | nr | nr |
Mef2c | MADS box transcription enhancer factor 2 | [115] | 1600662 | Chromosome 5q14.3 deletion syndrome | nr |
(Wnt1-Cre-mediated ablation) | Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations | ||||
Meox2 | Mesenchyme homeobox 2 | [116] | 1600535 | nr | nr |
Mn1 | Meningioma 1 | [117] | 1156100 | Meningioma | nr |
Mnt | Max binding protein | [118] | 1603039 | nr | nr |
Msx1 | Msh homeobox 1 | [10,23] | 1142983 | Ectodermal dysplasia 3, Witkop type | r |
Orofacial cleft 5 | |||||
Tooth agenesis, selective, 1, with or without orofacial cleft | |||||
Msx2 | Msh homeobox 2 | [119] | 1123101 | Craniosynostosis, type 2 | r |
(missense mutation) | Parietal foramina 1 | ||||
Parietal foramina with cleidocranial dysplasia | |||||
Nabp2/Obfc2b/hSSB1 | Nucleic acid binding protein 2 | [120,121] | 1612104 | nr | nr |
Osr2 | Odd-skipped related transcription factor 2 | [9] | 1611297 | nr | r |
Pak1ip1 | PAK1 interacting protein 1 | [122] | 1607811 | nr | nr |
Pax9 | Paired box gene 9 | [6] | 1167416 | Tooth agenesis, selective, 3 | nr |
Pbx1 | Pre B cell leukemia homeobox 1 | [83] | 1176310 | Leukemia, acute pre-B-cell | nr |
Pds5a | PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae) | [123] | 1613200 | nr | nr |
Phc1/Rae28 | Polyhomeotic homolog 1 | [124] | 1602978 | uc | nr |
Pitx1 | Paired-like homeodomain 1 | [7,125] | 1602149 | Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly | r |
Liebenberg syndrome | |||||
Pitx2 | Paired-like homeodomain 2 | [126] | 1601542 | Axenfeld-Rieger syndrome, type 1 | nr |
Iridogoniodysgenesis, type 2 | |||||
Peters anomaly | |||||
Pnn | Pinin | [127] | 1603154 | nr | nr |
Prdm16 | PR domain containing 16 | [128] | 1605557 | Cardiomyopathy, dilated, 1LL | nr |
Left ventricular noncompaction 8 | |||||
Prrx1/Prx1/Mhox | Paired related homeobox 1 | [129] | 1167420 | Agnathia-otocephaly complex | r |
Ptch1/Ptc1 | Patched 1 | [130] | 1601309 | Basal cell nevus syndrome | r |
(Wnt1-Cre-mediated ablation) | (Gorlin syndrome) | ||||
Holoprosencephaly type 7 | |||||
Pygo2 | Pygopus 2 | [131] | 1606903 | nr | nr |
(CMV-Cre-mediated ablation) | |||||
Rax | Retina and anterior neural fold homeobox | [132] | 1601881 | Microphthalmia, isolated 3 | nr |
Recql4 | RecQ protein-like 4 | [133] | 1603780 | Baller-Gerold syndrome | r |
RAPADILINO syndrome | |||||
Rothmund-Thomson syndrome | |||||
Runx2 | Runt-related transcription factor 2 | [134] | 1600211 | Cleidocranial dysplasia | r |
Sall3 | Spalt-like transcription factor 3 | [24] | 1605079 | nr | nr |
Satb2 | SATB homeobox 2 | [135,136] | 1608148 | Glass syndrome | r |
Shox2 | Short stature homeobox 2 | [22] | 1602504 | nr | nr |
Sim2 | Single-minded family bHLH transcription factor 2 | [137] | 1600892 | nr | nr |
Smad4 (Osr2-Cre-mediated ablation) | SMAD family member 4 | [138] | 1600993 | Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome | nr |
Myhre syndrome | |||||
Smad7 | SMAD family member 7 | [139] | 1602932 | uc | nr |
Snai2 | Snail family zinc finger 2 | [140] | 1602150 | Piebaldism | nr |
Waardenburg syndrome, type 2D | |||||
Sox5 | SRY (sex determining region Y)-box 5 | [141] | 1604975 | nr | nr |
Sox9 (heterozygous) | SRY (sex determining region Y)-box 9 | [142,143] | 1608160 | Acampomelic campomelic dysplasia | r |
(Wnt1-Cre-mediated ablation) | |||||
Sox11 | SRY (sex determining region Y)-box 11 | [144] | 1600898 | Mental retardation, autosomal dominant, 27 | nr |
Sp8 | Sp8 transcription factor | [145] | 1608306 | nr | nr |
Tshz1 | Teashirt zinc finger family member 1 | [146] | 1614427 | Aural atresia, congenital | nr |
Tbx1 | T-box 1 | [4,147] | 1602054 | DiGeorge syndrome | r |
(knockout) (KRT14-Cre-mediated ablation) | Velocardiofacial syndrome | ||||
Conotruncal anomaly face syndrome | |||||
Tetralogy of Fallot | |||||
Tbx2 | T-box 2 | [148] | 1600747 | nr | nr |
Tbx22 | T-box 22 | [149] | 1300307 | Cleft palate with ankyloglossia | r |
submucous cleft palate (SMCP) | |||||
Tcof1 | Treacher Collins-Franceschetti syndrome 1 | [150] | 1606847 | Treacher-Collins syndrome | r |
(heterozygous) | |||||
Tfap2A | Transcription factor AP-2 alpha | [151] | 1107580 | Branchio-oculo-facial syndrome | r |
(Wnt1-Cre-mediated ablation) | |||||
Trp63/Tp63 | Transformation related protein p63 | [152] | 1603273 | Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 | r |
Orofacial cleft 8 | |||||
Hay-Wells syndrome | |||||
Limb-mammary syndrome | |||||
Vax1 | Ventral anterior homeobox 1 | [153] | 1604294 | Microphthalmia, syndromic 11 | r |
Whsc1 | Wolf-Hirschhorn syndrome candidate 1 | [154] | 1602952 | nr | nr |
Zeb1 | Zinc finger E-box binding homeobox 1 | [155] | 1189909 | Corneal dystrophy | nr |
Zfp640/Mzf6d | Zinc finger protein 640 | [87] | nr | nr | nr |
Zic3 | Zinc finger protein of the cerebellum 3 | [156] | 1300265 | Congenital heart defects, nonsyndromic | r |
Heterotaxy, visceral, 1 | |||||
VACTERL association | |||||
Cytoplasmic proteins | |||||
Akap8/Akap95 | A kinase (PRKA) anchor protein 8 | [157] | 1604692 | nr | nr |
Apaf1 | Apoptotic peptidase activating factor 1 | [158] | 1602233 | nr | nr |
B9d1 | B9 protein domain 1 | [159] | 1614144 | Meckel syndrome 9 | nr |
Cask | Calcium/calmodulin-dependent serine protein kinase | [160] | 1300172 | FG syndrome 4 | r |
Mental retardation and microcephaly with pontine and cerebellar hypoplasia | |||||
Cdkn1c/p57kip2 | Cyclin-dependent kinase inhibitor 1C | [161,162] | 1600856 | Beckwith-Wiedemann syndrome | r |
IMAGe syndrome | |||||
Chuk/Ikk1/Tcf16 | Conserved helix-loop-helix ubiquitous kinase | [163] | 1600664 | Cocoon syndrome | nr |
Crk | v-crk sarcoma virus CT10 oncogene homolog | [164] | 1164762 | nr | nr |
Ctnnb1 | Catenin (cadherin-associated protein), beta 1, | [165,166] | 1116806 | Mental retardation, autosomal dominant 19 | nr |
(KRT14-Cre-mediated ablation) | |||||
Cyp26B1 | Cytochrome P450, family 26, subfamily b, polypeptide 1 | [167] | 1605207 | Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies | nr |
Cyp51 | Cytochrome P450, family 51 | [168] | 1601637 | nr | nr |
Dhcr7 | 7-dehydrocholesterol reductase | [169,170] | 1602858 | Smith-Lemli-Opitz syndrome | r |
Dhrs3 | Dehydrogenase/reductase (SDR family) member 3 | [171,172] | 1612830 | nr | nr |
Dicer1 | Dicer 1, ribonuclease type III | [29] | 1606241 | Rhabdomyosarcoma, embryonal, 2 | nr |
(Pax2-Cre-mediated ablation) | Goiter, multinodular 1 | ||||
Pleuropulmonary blastoma | |||||
Dlg1/Dlgh/Sap97 | Discs large 1 | [173] | 1601014 | nr | nr |
Fuz | Fuzzy planar cell polarity protein | [174] | 1610622 | Neural tube defects | nr |
Gab1 | Growth factor receptor bound protein 2-associated protein 1 | [175] | 1604439 | nr | nr |
Gad1/Gad67 | Glutamate decarboxylase 1 | [176,177] | 1605363 | Cerebral palsy, spastic quadriplegic, 1 | r |
Glce | Glucuronyl C5-epimerase | [178] | 1612134 | nr | nr |
Glg1 | Golgi apparatus protein 1 | [179] | 1600753 | nr | nr |
Grb2 | Growth factor receptor bound protein 2 | [180] | 1108355 | nr | nr |
Gsk3b | Glycogen synthase kinase 3 beta | [181] | 1605004 | nr | nr |
Hs2st1 | Heparan sulfate 2-O-sulfotransferase 1 | [182] | 1604844 | nr | nr |
Hspb11/Ift25 | Heat shock protein family B (small), member 11 | [183] | 1604844 | nr | nr |
Ilk | Integrin linked kinase | [184] | 1602366 | nr | nr |
(Col2a1-Cre-mediated ablation) | |||||
Impad1/Jaws | Inositol monophosphatase domain containing 1 | [185] | 1614010 | Chondrodysplasia with joint dislocations, GRAPP type | r |
Inpp5e | Inositol polyphosphate-5-phosphatase E | [186] | 1613037 | Joubert syndrome 1 | nr |
Mental retardation, truncal obesity, retinal dystrophy, and micropenis | |||||
Kif3a | Kinesin family member 3A | [187] | 1604683 | nr | nr |
(Wnt1-Cre-mediated ablation) | |||||
Map3k7/Tak1 | Mitogen-activated protein kinase kinase kinase 7 | [188,189] | 1602614 | nr | nr |
(Wnt1-Cre-mediated ablation) | |||||
Nprl3 | Nitrogen permease regulator-like 3 | [190] | 1600928 | nr | nr |
Ofd1 | Oral-facial-digital syndrome 1 gene homolog (human) | [191] | 1300170 | Joubert syndrome 10 | r |
(CAG-Cre-mediated ablation) | Orofaciodigital syndrome I | ||||
Simpson-Golabi-Behmel syndrome, type 2 | |||||
Pdss2 | Prenyl (solanesyl) diphosphate synthase, subunit 2 | [192] | 1610564 | Coenzyme Q10 deficiency, primary, 3 | nr |
(Pax2-Cre-mediated ablation) | |||||
Piga | Phosphatidylinositol glycan anchor biosynthesis, class A | [193] | 1311770 | Multiple congenital anomalies-hypotonia-seizures syndrome 2 Paroxysmal nocturnal hemoglobinuria, somatic | nr |
(EIIa-Cre-mediated ablation) | |||||
Pkdcc/Vlk | Protein kinase domain containing, cytoplasmic | [194,195] | 1614150 | nr | nr |
(Sox2-Cre-mediated ablation) | |||||
Prickle1 | Prickle homolog 1 | [196] | 1608500 | Epilepsy, progressive myoclonic 1B | nr |
Rad23b | RAD23b homolog (S. cerevisiae) | [197] | 1600062 | nr | nr |
Rspo2 | R-spondin 2 homolog (Xenopus laevis) | [198,199] | 1610575 | nr | nr |
Schip1 | Schwannomin interacting protein 1 | [87] | nr | nr | nr |
Sdccag8 | Serologically defined colon cancer antigen 8 | [200] | 1613524 | Bardet-Biedl syndrome 16 | nr |
Senior-Loken syndrome 7 | |||||
Slc32a1/Viaat | Solute carrier family 32, member 1 | [201,202] | nr | nr | nr |
Spry1 | Sprouty homolog 1 | [203] | 1602465 | nr | nr |
(Wnt1-Cre-mediated ablation) | |||||
Spry2 | Sprouty homolog 2 | [204] | 1602466 | nr | nr |
Sumo1 | SMT3 suppressor of mif two 3 homolog 1 (yeast) | [205] | 1601912 | Orofacial cleft 10 | r |
(heterozygous) | |||||
Ugdh | UDP-glucose dehydrogenase | [206] | 1603370 | nr | nr |
(Wnt1-Cre-mediated ablation) | |||||
Wdpcp | WD repeat containing planar cell polarity effector | [207] | 1613580 | uc | nr |
Extracellular proteins | |||||
Col2a1 | Collagen, type II, alpha 1 | [208] | 2120140 | Achondrogenesis, type II | r |
Stickler syndrome, type I | |||||
Kniest dysplasia | |||||
Hspg2 | Heparan sulfate proteoglycan 2, perlecan | [209,210] | 1142461 | Dyssegmental dysplasia | nr |
Schwartz-Jampel syndrome, type 1 | |||||
Serpinh1/Hsp47 | Serpine peptidase inhibitor, clade H, member 1 | [211] | 1600943 | Osteogenesis imperfecta, type X | nr |
(Col2a1-Cre-mediated ablation) | |||||
Smoc1 | SPARC related modular calcium binding 1 | [212] | 1608488 | Microphthalmia with limb anomalies | r |
Genes | |
Signaling pathway | |
TGF-beta signaling pathway | Acvr1/Alk2, Acvr2a, Bmp41, Bmp7, Bmpr1a/Alk3, Cdc42, Chrd, Crebbp/Cbp, Cited2, Foxc2/Mfh11, Foxd3, Foxe1/Titf2/Fkhl151, Foxf2, Fst, Inhba, Gdf11/Bmp11, Map3k7/Tak1, Pitx2, Smad4, Smad7, Tgfb21, Tgfb31, Tgfbr1/Alk51, Tgfbr21 |
Hedgehog signaling pathway | Bmp41, Bmp7, Crebbp/Cbp, Gli21, Gli31, Gsk3b, Ptch1/Ptc11, Shh1, Smo/Smoh, Wnt5a1, Wnt9b |
Wnt signaling pathway | Acvr1/Alk2, Ctnnb1, Crebbp/Cbp, Edn11, Fzd2, Gsk3b, Lrp6, Map3k7/Tak1, Prickle1, Smad4, Smo/Smoh, Wnt5a1, Wnt9b |
FGF signaling pathway | Fgf10, Fgf18, Fgf9, Fgfr11, Fgfr21, Grb2, Spry1, Spry2 |
MAPK signaling pathway | Cdc42, Chuk/Ikk1/Tcf16, Egfr, Fgf10, Fgf18, Fgf9, Fgfr11, Fgfr21, Grb2, Map3k7/Tak1, Pdgfra1, Tgfb21, Tgfb31, Tgfbr1/Alk51, Tgfbr21, Crk, Itgb1 |
Cytokine-cytokine receptor interaction | Acvr1/Alk2, Acvr2a, Bmp7, Bmpr1a/Alk3, Egfr, Inhba, Pdgfra1, Pdgfc1, Tgfb21, Tgfb31, Tgfbr1/Alk51, Tgfbr21, Vegfa |
CBL mediated ligand- induced downregulation of EGF receptors | Egfr, Grb2, Pdgfra1 |
Sprouty regulation of tyrosine kinase signals | Egfr, Grb2, Spry2, Spry1 |
NFkB activation | Crebbp/Cbp, Chuk/Ikk1/Tcf16, Map3k7/Tak1, Smad4, Tgfbr1/Alk51, Tgfbr21 |
Adherens junction | Crebbp/Cbp, Ctnnb1, Cdc42, Egfr, Fgfr11, Map3k7/ Tak1, Smad4, Snai2, Tgfbr1/Alk51, Tgfbr21 |
Focal adhesion | Ctnnb1, Cdc42, Col2a11, Crk, Egfr, Gsk3b, Grb2, Itga5, Itgb1, Itgb8, Ilk, Pdgfra1, Pdgfc1, Vegfa |
Steroid biosynthesis | Cyp51, Dhcr71, Sc5d/Sc5dl |
Cell cycle | Crebbp/Cbp, Cdkn1c/p57kip21, Gsk3b, Smad4, Tgfb21, Tgfb31 |
Regulation of actin cytoskeleton | Cdc42, Crk, Egfr, Fgf9, Fgf10, Fgf18, Fgfr11, Fgfr21, Itga5, Itgb1, Itgb8, Pdgfra1, Pdgfc1 |
Axon guidance | Cdc42, Efna5, Efnb11, Efnb2, Gsk3b, Itgb1 |
Endocytosis | Cdc42, Egfr, Fgfr21, Pdgfra1, Tgfbr1/Alk51, Tgfbr21 |
Angiogenesis | Ctnnb1, Crk, Efnb11, Efnb2, Fgfr11, Fgfr21, Fzd2, Gsk3b, Grb2, Jag1, Jag2, Pdgfra1, Pdgfc1, Vegfa, Wnt5a1 |
Family | |
Homeobox protein | Alx11, Barx1, Alx31, Alx41, Dlx1, Dlx2, Dlx51, Gbx2, Gsc, Hoxa21, Msx11, Msx21, Pax9, Prrx11, Pitx11, Pitx2, Rax, Shox2, Vax11 |
Tgf-beta receptor type I and II | Acvr1/Alk2, Acvr2a, Bmpr1a, Tgfbr1/Alk51, Tgfbr21 |
Tgf-beta family | Bmp41, Bmp7, Gdf11, Inhba, Tgfb21, Tgfb31 |
Tyrosine protein kinase | Egfr, Fgfr11, Fgfr21, Pdgfra1, Ror21, Ryk |
Ephrin | Efna5, Efnb11, Efnb2 |
Zinc finger protein | Gli21, Gli31, Zic31, Hic1, Snai2 |
Forkhead protein | Foxc21, Foxd3, Foxe11, Foxf2 |
T-box protein | Tbx11, Tbx2, Tbx221 |
Sox transcription factor | Sox5, Sox91, Sox11 |
Heparin-binding growth factor family member/FGF | Fgf9, Fgf10, Fgf18 |
Sprouty | Spry1, Spry2 |
Smad | Smad4, Smad7 |
Integrin beta subunit | Itgb1, Itgb8 |
Frizzled | Fzd2, Smo |
Wnt related | Wnt5a1, Wnt9b |
Serine-threonine protein kinase | Ilk, Mpa3k7/Tak1 |
LIM domain containing protein | Lhx81, Lhx7, Prickle1 |
EGF-like domain protein | Jag1, Jag2 |
Defects | Knockout mice | |
(1) | Failure of the palatal shelf formation (small palatal shelves) | Acvr2a[34,50], 1Fgfr2[13], 1Lhx8[11], Pitx2[126], Itga5[65], Fst[46] |
(2) | Abnormal fusion of palatal shelves and tongue or the mandible | Jag2[70], 1Irf6[109,110], 1Tbx1[4], Fgf10[41] |
(3) | Failure or delayed palatal shelf elevation | Pax9[6], 1Pitx1[7], 1Osr2[9], 1Gli2[8], 1Tgfb2[55], 1Pdgfc[51], Dhrs3[172] |
(4) | Failure of the palatal shelf development after the elevation | 1Msx1[10], 1Lhx8[11], 1Tgfbr2 (Wnt1-Cre-mediated ablation)[12] |
(5) | Persistence of medial edge epithelial cells | Apaf1[158], 1Tgfb3[18], Egfr[17], Ctnnb1 (K14-Cre-mediated ablation)[166] |
(6) | Secondary defect | 1Hoxa2[19,20], 1Satb2[135], Acvr1/Alk2 (Wnt1-Cre-mediated ablation)[33] |
- Citation: Funato N, Nakamura M, Yanagisawa H. Molecular basis of cleft palates in mice. World J Biol Chem 2015; 6(3): 121-138
- URL: https://www.wjgnet.com/1949-8454/full/v6/i3/121.htm
- DOI: https://dx.doi.org/10.4331/wjbc.v6.i3.121